Shandong Pharmaceutical Glass Co (SHSE:600529) LT-Debt-to-Total-Asset : 0.00 (As of Mar. 2024)

View and export this data going back to 2002. Start your Free Trial

What is Shandong Pharmaceutical Glass Co LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Shandong Pharmaceutical Glass Co's long-term debt to total assests ratio for the quarter that ended in Mar. 2024 was 0.00.

Shandong Pharmaceutical Glass Co's long-term debt to total assets ratio stayed the same from Mar. 2023 (0.00) to Mar. 2024 (0.00).

Shandong Pharmaceutical Glass Co LT-Debt-to-Total-Asset Historical Data

The historical data trend for Shandong Pharmaceutical Glass Co's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Pharmaceutical Glass Co LT-Debt-to-Total-Asset Chart

Shandong Pharmaceutical Glass Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

Shandong Pharmaceutical Glass Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															-	-	-	-	-

Shandong Pharmaceutical Glass Co LT-Debt-to-Total-Asset Calculation

Shandong Pharmaceutical Glass Co's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (A: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2023 )	/	Total Assets (A: Dec. 2023 )
	=	0	/	9318.722
	=	0.00

Shandong Pharmaceutical Glass Co's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

LT Debt to Total Assets (Q: Mar. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Mar. 2024 )	/	Total Assets (Q: Mar. 2024 )
	=	0	/	9588.071
	=	0.00

Shandong Pharmaceutical Glass Co (SHSE:600529) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Shandong Pharmaceutical Glass Co LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Shandong Pharmaceutical Glass Co's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Shandong Pharmaceutical Glass Co (SHSE:600529) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Packaging & Containers » Shandong Pharmaceutical Glass Co Ltd (SHSE:600529) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

Yaobo Road, Yiyuan County, Zibo, Shandong, CHN, 256100

Website

http://www.pharmglass.com

Shandong Pharmaceutical Glass Co Ltd is a pharmaceutical glass packaging product company. Its pharmaceutical glass packaging products and butyl rubber series products which service object of pharmaceutical, food, daily necessities industries. The products include for moulded injection vial for antibiotics series, tubular glass vial series, amber glass bottle series, neutral borosilicate glass bottle series, infusion bottle series, cosmetic bottles series, food bottles series, butyl rubber stopper series, prefillable syringes series, and aluminum-plastic cap series.

Shandong Pharmaceutical Glass Co (SHSE:600529) Headlines

No Headlines